Viewing Study NCT03982004


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-03-28 @ 7:10 AM
Study NCT ID: NCT03982004
Status: TERMINATED
Last Update Posted: 2021-06-21
First Post: 2019-06-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Sponsor:
Organization: